Source:http://linkedlifedata.com/resource/pubmed/id/14505826
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-9-24
|
pubmed:abstractText |
Several thrombogenic abnormalities are associated with diabetes. Since endothelial dysfunction occurs at early stages of disease, it may reflect pathophysiological changes that are responsible for alterations in vascular structure, growth and modifications of adhesivity to platelets and leukocytes, leading to atherosclerosis and thrombosis. Predisposing factors of vascular diseases, such as diabetes, are also associated with endothelial dysfunction. Restoration or replacement of endothelium-related factors like nitric oxide impede the progression of vascular thrombogenic diseases, and prevent the action of vasoconstrictor factors such as endothelin or other prothrombotic factors such as plasminogen-activator inhibitor-1. Since high glucose concentration in blood is the hallmark of diabetes and because the vascular lesions of atherosclerosis are localized in large artheries, we have cultured endothelial cells from the human aorta. Two endothelial cell strains from the same aortic tract that show different characteristics and behavior in high glucose were isolated. Such findings reflect the importance to have well characterized and standardized cell culture systems to carry out experiments to study the glucose-dependent atherosclerotic process in vitro. Our cell strains may represent a useful in vitro model to study the complex pathophysiology of diabetes-related atherosclerosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0300-9084
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
701-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14505826-Antigens, CD31,
pubmed-meshheading:14505826-Biological Factors,
pubmed-meshheading:14505826-Cell Differentiation,
pubmed-meshheading:14505826-Cells, Cultured,
pubmed-meshheading:14505826-Diabetes Mellitus,
pubmed-meshheading:14505826-Diabetic Angiopathies,
pubmed-meshheading:14505826-Endothelium, Vascular,
pubmed-meshheading:14505826-Glucose,
pubmed-meshheading:14505826-Humans,
pubmed-meshheading:14505826-Models, Cardiovascular,
pubmed-meshheading:14505826-Vascular Diseases,
pubmed-meshheading:14505826-von Willebrand Factor
|
pubmed:year |
2003
|
pubmed:articleTitle |
New in vitro model to study high glucose-dependent endothelial dysfunctions.
|
pubmed:affiliation |
Dipartimento di Patologia e Medicina Sperimentale e Clinica, Universita' degli Studi di Udine, P.le S.Maria della Misericordia, 33100, Udine, Italy. donnini@dpmsc.uniud.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|